Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-16

Clinical Trial Update: Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology

View source ↗

Summary

A completed trial evaluating the effects of long-term AMG 531 (romiplostim) dosing on bone marrow morphology in patients with idiopathic thrombocytopenic purpur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Romiplostim (romiplostim)

Snippet

Sponsor: Amgen | Conditions: Idiopathic Thrombocytopenic Purpura | Status: COMPLETED